SCHEMBL5097156

SCHEMBL5097156

CN1CCCN(c2ccc3cnn(S(=O)(=O)c4ccc5c(c4)OCCN5C)c3c2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
CYP2C19 P33261 1/20 0.42
GBA1 P04062 1/20 0.42
HTR6 P50406 7/20 0.40
HTR1A P08908 3/20 0.40
DRD3 P35462 3/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
DRD4 P21917 1/20 0.40
HTR7 P34969 1/20 0.40
USP9X Q93008 1/20 0.40
HTT P42858 2/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
DRD2 P14416 2/20 0.39
GHSR Q92847 1/20 0.39
POLB P06746 1/20 0.38
PTGES2 Q9H7Z7 1/20 0.37
HCRTR1 O43613 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103502 0.96 GBA1 (0.44) PKMCYP2C19GBA1HTR6HTR1A
SCHEMBL5097122 0.88 GHSR (0.39) GBA1HTR6DRD3USP9XHTT
SCHEMBL5103449 0.88 GHSR (0.41) GBA1HTR6DRD3USP9XHTT
SCHEMBL5095143 0.84 HTR6 (0.58) PKMCYP2C19GBA1HTR6HTR1A
SCHEMBL5091052 0.81 PKM (0.43) PKMHTR6DRD3USP9XL3MBTL1
SCHEMBL5097493 0.80 GBA1 (0.44) PKMCYP2C19GBA1USP9XHTT
SCHEMBL5091091 0.80 USP9X (0.47) PKMHTR6HTR1ADRD3HTR2A
SCHEMBL14100622 0.80 HTR6 (0.62) GBA1HTR6HTR1AUSP9XHTT
SCHEMBL5103393 0.79 CHRM1 (0.43) PKMHTR6HTR1ADRD3HTR2A
SCHEMBL14140333 0.77 USP9X (0.42) PKMCYP2C19GBA1HTR6DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US claimed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
WO-2008101247-A2 6 ' SUBSTITUTED INDOLE AND INDAZOLE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A PKM 3556/4885CYP2C19 336/4885GBA1 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.